Introduction
Methods
Study population
Intervention – use of MOLLI guidance system
Radiology
Surgery
Pathology
Outcomes
Statistical analysis
Results
Average ± SE (n = 20) | |
---|---|
Age (years) | 60.3 ± 13.0 |
Height (m) | 1.6 ± 0.1 |
Weight (kg) | 66.7 ± 12.6 |
Menopausal status | |
Pre | 6 |
Post | 14 |
Tumor type | |
DCIS | 3 |
IDC | 12 |
Other | 5 |
Receptor status | |
ER/PR+, HER2− | 10 |
ER−/PR+, HER2− | 1 |
ER/PR−, HER2− | 1 |
Not evaluateda | 8 |
Largest tumor size (mm on imaging) | 15.7 ± 8.7 |
BIRADS category | |
5 | 10 |
4 | 10 |
Tumor stage | |
p2a | 4 |
p1a | 8 |
p0 | 5 |
Not applicable | 3 |
Tumor grade | |
3 | 5 |
2 | 8 |
1 | 4 |
Not evaluated | 3 |
Multifocal disease | |
Yes | 1 |
No | 19 |
Lymph node metastases | |
Yes | 3 |
No | 9 |
Not evaluated | 8 |
Radiology | |
Days prior to surgical procedure; mean (range) | 1.25 (0–7) |
Number of radiologists | 7 |
Marker placed in lesion center | 17 |
Marker successfully placed | 20 |
Total procedure time; mean (range) | 11.85 (– 35) min |
Surgery | |
Number of surgeons | 2 |
Marker found before incision | 20 |
Marker depth from skin; mean (range) | 13.6 (8–29) mm |
Marker successfully removed | 20 |
Marker in lesion center | 13 |
Marker in specimen | 20 |
RSL needed to confirm position | 2 |
Total operative time; mean (range) | 36.3 (21–80) min |
Pathology | |
Number of pathologists | 6 |
Negative margins | 20 |
Marker removed | 20 |
Re-excision required | 0 |